Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India

Aim We aimed to study host range, stability, genome and antibiofilm activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant (MDR) and extensively drug‐resistant (XDR) biofilm‐forming uropathogenic Escherichia coli isolates. Methods and Results A novel lytic phage vB_EcoA_RDN8.1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied microbiology 2022-04, Vol.132 (4), p.3387-3404
Hauptverfasser: Chaudhary, Naveen, Mohan, Balvinder, Mavuduru, Ravimohan S., Kumar, Yashwant, Taneja, Neelam
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3404
container_issue 4
container_start_page 3387
container_title Journal of applied microbiology
container_volume 132
creator Chaudhary, Naveen
Mohan, Balvinder
Mavuduru, Ravimohan S.
Kumar, Yashwant
Taneja, Neelam
description Aim We aimed to study host range, stability, genome and antibiofilm activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant (MDR) and extensively drug‐resistant (XDR) biofilm‐forming uropathogenic Escherichia coli isolates. Methods and Results A novel lytic phage vB_EcoA_RDN8.1 active against UPEC strains resistant to third‐generation cephalosporins, fluoroquinolones, aminoglycosides, imipenem, beta‐lactamase inhibitor combination and polymyxins was isolated from community raw sewage water of Chandigarh. It exhibited a clear plaque morphology and a burst size of 250. In the time‐kill assay, the maximum amount of killing was achieved at MOI 1.0. vB_EcoA_RDN8.1 belongs to the family Autographiviridae, has a genome size of 39.5 kb with a GC content of 51.6%. It was stable over a wide range of temperatures and pH. It was able to inhibit biofilm formation which may be related to an endolysin encoded by ORF 19. Conclusions The vB_EcoA_RDN8.1 is a novel lytic phage that has the potential for inclusion into phage cocktails being developed for the treatment of urinary tract infections (UTIs) caused by highly drug‐resistant UPEC. Significance and Impact of the Study We provide a detailed characterization of a novel lytic Escherichia phage with antibiofilm activity having a potential application against MDR and XDR UPEC causing UTIs.
doi_str_mv 10.1111/jam.15439
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2617275229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2644357512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-5d96c69d500a982e96855c833ac314478c9590ac83c856ff5a586bed49e5a9893</originalsourceid><addsrcrecordid>eNp1kd-K1DAUh4so7h-98AUk4I3CdrZpmra5HMdRV1YF0etwJk3bDGkyJum49cpH8A0Fn8TMdFUQzE0OJ18-DueXJI9wtsDxXG5hWGBaEHYnOcWkpGleVvndY12kNKvyk-TM-22WYZLR8n5yQgpWs6yip8mPVQ8ORJBOfYWgrLlAnTR2kAgM6MkrH4sGKYP2KjiLIqpiNSHbIkDG7qVGux46ifbP-VrYJf_w4l29wDMYLR0o4wMaRh3Uz2_fGzd2yMnoDWDC0S1vgjQ-wnpCh-dI_QU2yrZKD7HXWjco06HR2R2E3sYxlUBrL_o4u-gVIGG1QspbDUH6C3RlGgUPknstaC8f3t7nyaeX64-r1-n1-1dXq-V1KgglLKUNK0XJGpplwOpcsrKmVNSEgCC4KKpaMMoyiB1R07JtKdC63MimYJLGD4ycJ09n787Zz6P0gQ_KC6k1GGlHz_MSV3lF8_yAPvkH3drRxW0fqKIgtKI4j9SzmRLOeu9ky3dODeAmjjN-SJ3H1Pkx9cg-vjWOm0E2f8jfMUfgcga-KC2n_5v4m-XbWfkL6z-9vA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644357512</pqid></control><display><type>article</type><title>Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Chaudhary, Naveen ; Mohan, Balvinder ; Mavuduru, Ravimohan S. ; Kumar, Yashwant ; Taneja, Neelam</creator><creatorcontrib>Chaudhary, Naveen ; Mohan, Balvinder ; Mavuduru, Ravimohan S. ; Kumar, Yashwant ; Taneja, Neelam</creatorcontrib><description>Aim We aimed to study host range, stability, genome and antibiofilm activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant (MDR) and extensively drug‐resistant (XDR) biofilm‐forming uropathogenic Escherichia coli isolates. Methods and Results A novel lytic phage vB_EcoA_RDN8.1 active against UPEC strains resistant to third‐generation cephalosporins, fluoroquinolones, aminoglycosides, imipenem, beta‐lactamase inhibitor combination and polymyxins was isolated from community raw sewage water of Chandigarh. It exhibited a clear plaque morphology and a burst size of 250. In the time‐kill assay, the maximum amount of killing was achieved at MOI 1.0. vB_EcoA_RDN8.1 belongs to the family Autographiviridae, has a genome size of 39.5 kb with a GC content of 51.6%. It was stable over a wide range of temperatures and pH. It was able to inhibit biofilm formation which may be related to an endolysin encoded by ORF 19. Conclusions The vB_EcoA_RDN8.1 is a novel lytic phage that has the potential for inclusion into phage cocktails being developed for the treatment of urinary tract infections (UTIs) caused by highly drug‐resistant UPEC. Significance and Impact of the Study We provide a detailed characterization of a novel lytic Escherichia phage with antibiofilm activity having a potential application against MDR and XDR UPEC causing UTIs.</description><identifier>ISSN: 1364-5072</identifier><identifier>EISSN: 1365-2672</identifier><identifier>DOI: 10.1111/jam.15439</identifier><identifier>PMID: 34989075</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aminoglycosides ; Bacteriophages - genetics ; Biofilms ; Burst size ; Cephalosporins ; Drug resistance ; E coli ; Escherichia coli ; Fluoroquinolones ; Genomes ; Host range ; Humans ; Imipenem ; multidrug‐resistance ; Myoviridae ; Open reading frames ; phage cocktail ; phage therapy ; Phages ; Polymyxins ; Raw sewage ; Sewage ; Urinary tract ; Urinary Tract Infections ; uropathogenic Escherichia coli ; Uropathogenic Escherichia coli - genetics</subject><ispartof>Journal of applied microbiology, 2022-04, Vol.132 (4), p.3387-3404</ispartof><rights>2022 The Society for Applied Microbiology</rights><rights>2022 The Society for Applied Microbiology.</rights><rights>Copyright © 2022 The Society for Applied Microbiology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-5d96c69d500a982e96855c833ac314478c9590ac83c856ff5a586bed49e5a9893</citedby><cites>FETCH-LOGICAL-c3539-5d96c69d500a982e96855c833ac314478c9590ac83c856ff5a586bed49e5a9893</cites><orcidid>0000-0003-1198-6138</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjam.15439$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjam.15439$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34989075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chaudhary, Naveen</creatorcontrib><creatorcontrib>Mohan, Balvinder</creatorcontrib><creatorcontrib>Mavuduru, Ravimohan S.</creatorcontrib><creatorcontrib>Kumar, Yashwant</creatorcontrib><creatorcontrib>Taneja, Neelam</creatorcontrib><title>Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India</title><title>Journal of applied microbiology</title><addtitle>J Appl Microbiol</addtitle><description>Aim We aimed to study host range, stability, genome and antibiofilm activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant (MDR) and extensively drug‐resistant (XDR) biofilm‐forming uropathogenic Escherichia coli isolates. Methods and Results A novel lytic phage vB_EcoA_RDN8.1 active against UPEC strains resistant to third‐generation cephalosporins, fluoroquinolones, aminoglycosides, imipenem, beta‐lactamase inhibitor combination and polymyxins was isolated from community raw sewage water of Chandigarh. It exhibited a clear plaque morphology and a burst size of 250. In the time‐kill assay, the maximum amount of killing was achieved at MOI 1.0. vB_EcoA_RDN8.1 belongs to the family Autographiviridae, has a genome size of 39.5 kb with a GC content of 51.6%. It was stable over a wide range of temperatures and pH. It was able to inhibit biofilm formation which may be related to an endolysin encoded by ORF 19. Conclusions The vB_EcoA_RDN8.1 is a novel lytic phage that has the potential for inclusion into phage cocktails being developed for the treatment of urinary tract infections (UTIs) caused by highly drug‐resistant UPEC. Significance and Impact of the Study We provide a detailed characterization of a novel lytic Escherichia phage with antibiofilm activity having a potential application against MDR and XDR UPEC causing UTIs.</description><subject>Aminoglycosides</subject><subject>Bacteriophages - genetics</subject><subject>Biofilms</subject><subject>Burst size</subject><subject>Cephalosporins</subject><subject>Drug resistance</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Fluoroquinolones</subject><subject>Genomes</subject><subject>Host range</subject><subject>Humans</subject><subject>Imipenem</subject><subject>multidrug‐resistance</subject><subject>Myoviridae</subject><subject>Open reading frames</subject><subject>phage cocktail</subject><subject>phage therapy</subject><subject>Phages</subject><subject>Polymyxins</subject><subject>Raw sewage</subject><subject>Sewage</subject><subject>Urinary tract</subject><subject>Urinary Tract Infections</subject><subject>uropathogenic Escherichia coli</subject><subject>Uropathogenic Escherichia coli - genetics</subject><issn>1364-5072</issn><issn>1365-2672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kd-K1DAUh4so7h-98AUk4I3CdrZpmra5HMdRV1YF0etwJk3bDGkyJum49cpH8A0Fn8TMdFUQzE0OJ18-DueXJI9wtsDxXG5hWGBaEHYnOcWkpGleVvndY12kNKvyk-TM-22WYZLR8n5yQgpWs6yip8mPVQ8ORJBOfYWgrLlAnTR2kAgM6MkrH4sGKYP2KjiLIqpiNSHbIkDG7qVGux46ifbP-VrYJf_w4l29wDMYLR0o4wMaRh3Uz2_fGzd2yMnoDWDC0S1vgjQ-wnpCh-dI_QU2yrZKD7HXWjco06HR2R2E3sYxlUBrL_o4u-gVIGG1QspbDUH6C3RlGgUPknstaC8f3t7nyaeX64-r1-n1-1dXq-V1KgglLKUNK0XJGpplwOpcsrKmVNSEgCC4KKpaMMoyiB1R07JtKdC63MimYJLGD4ycJ09n787Zz6P0gQ_KC6k1GGlHz_MSV3lF8_yAPvkH3drRxW0fqKIgtKI4j9SzmRLOeu9ky3dODeAmjjN-SJ3H1Pkx9cg-vjWOm0E2f8jfMUfgcga-KC2n_5v4m-XbWfkL6z-9vA</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Chaudhary, Naveen</creator><creator>Mohan, Balvinder</creator><creator>Mavuduru, Ravimohan S.</creator><creator>Kumar, Yashwant</creator><creator>Taneja, Neelam</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1198-6138</orcidid></search><sort><creationdate>202204</creationdate><title>Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India</title><author>Chaudhary, Naveen ; Mohan, Balvinder ; Mavuduru, Ravimohan S. ; Kumar, Yashwant ; Taneja, Neelam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-5d96c69d500a982e96855c833ac314478c9590ac83c856ff5a586bed49e5a9893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aminoglycosides</topic><topic>Bacteriophages - genetics</topic><topic>Biofilms</topic><topic>Burst size</topic><topic>Cephalosporins</topic><topic>Drug resistance</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Fluoroquinolones</topic><topic>Genomes</topic><topic>Host range</topic><topic>Humans</topic><topic>Imipenem</topic><topic>multidrug‐resistance</topic><topic>Myoviridae</topic><topic>Open reading frames</topic><topic>phage cocktail</topic><topic>phage therapy</topic><topic>Phages</topic><topic>Polymyxins</topic><topic>Raw sewage</topic><topic>Sewage</topic><topic>Urinary tract</topic><topic>Urinary Tract Infections</topic><topic>uropathogenic Escherichia coli</topic><topic>Uropathogenic Escherichia coli - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chaudhary, Naveen</creatorcontrib><creatorcontrib>Mohan, Balvinder</creatorcontrib><creatorcontrib>Mavuduru, Ravimohan S.</creatorcontrib><creatorcontrib>Kumar, Yashwant</creatorcontrib><creatorcontrib>Taneja, Neelam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chaudhary, Naveen</au><au>Mohan, Balvinder</au><au>Mavuduru, Ravimohan S.</au><au>Kumar, Yashwant</au><au>Taneja, Neelam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India</atitle><jtitle>Journal of applied microbiology</jtitle><addtitle>J Appl Microbiol</addtitle><date>2022-04</date><risdate>2022</risdate><volume>132</volume><issue>4</issue><spage>3387</spage><epage>3404</epage><pages>3387-3404</pages><issn>1364-5072</issn><eissn>1365-2672</eissn><abstract>Aim We aimed to study host range, stability, genome and antibiofilm activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant (MDR) and extensively drug‐resistant (XDR) biofilm‐forming uropathogenic Escherichia coli isolates. Methods and Results A novel lytic phage vB_EcoA_RDN8.1 active against UPEC strains resistant to third‐generation cephalosporins, fluoroquinolones, aminoglycosides, imipenem, beta‐lactamase inhibitor combination and polymyxins was isolated from community raw sewage water of Chandigarh. It exhibited a clear plaque morphology and a burst size of 250. In the time‐kill assay, the maximum amount of killing was achieved at MOI 1.0. vB_EcoA_RDN8.1 belongs to the family Autographiviridae, has a genome size of 39.5 kb with a GC content of 51.6%. It was stable over a wide range of temperatures and pH. It was able to inhibit biofilm formation which may be related to an endolysin encoded by ORF 19. Conclusions The vB_EcoA_RDN8.1 is a novel lytic phage that has the potential for inclusion into phage cocktails being developed for the treatment of urinary tract infections (UTIs) caused by highly drug‐resistant UPEC. Significance and Impact of the Study We provide a detailed characterization of a novel lytic Escherichia phage with antibiofilm activity having a potential application against MDR and XDR UPEC causing UTIs.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34989075</pmid><doi>10.1111/jam.15439</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-1198-6138</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1364-5072
ispartof Journal of applied microbiology, 2022-04, Vol.132 (4), p.3387-3404
issn 1364-5072
1365-2672
language eng
recordid cdi_proquest_miscellaneous_2617275229
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current)
subjects Aminoglycosides
Bacteriophages - genetics
Biofilms
Burst size
Cephalosporins
Drug resistance
E coli
Escherichia coli
Fluoroquinolones
Genomes
Host range
Humans
Imipenem
multidrug‐resistance
Myoviridae
Open reading frames
phage cocktail
phage therapy
Phages
Polymyxins
Raw sewage
Sewage
Urinary tract
Urinary Tract Infections
uropathogenic Escherichia coli
Uropathogenic Escherichia coli - genetics
title Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T00%3A41%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization,%20genome%20analysis%20and%20in%20vitro%20activity%20of%20a%20novel%20phage%20vB_EcoA_RDN8.1%20active%20against%20multi%E2%80%90drug%20resistant%20and%20extensively%20drug%E2%80%90resistant%20biofilm%E2%80%90forming%20uropathogenic%20Escherichia%20coli%20isolates,%20India&rft.jtitle=Journal%20of%20applied%20microbiology&rft.au=Chaudhary,%20Naveen&rft.date=2022-04&rft.volume=132&rft.issue=4&rft.spage=3387&rft.epage=3404&rft.pages=3387-3404&rft.issn=1364-5072&rft.eissn=1365-2672&rft_id=info:doi/10.1111/jam.15439&rft_dat=%3Cproquest_cross%3E2644357512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2644357512&rft_id=info:pmid/34989075&rfr_iscdi=true